Testimony of:  
Daniel R. Levinson 
Inspector General  
U.S. Department of Health & Human Services  
______________________________________________________________________________ 
 
Good morning, Chairmen Waxman and Pallone, Ranking Members Barton and Shimkus, and 
other distinguished Members of the Subcommittee.  I am Daniel Levinson, Inspector General of 
the U.S. Department of Health & Human Services (HHS or the Department).  Thank you for the 
opportunity to discuss new tools in the recently enacted Patient Protection and Affordable Care 
Act (Affordable Care Act or ACA) that will help to combat fraud, waste, and abuse in the health 
care system.  My testimony will describe OIGs strategy for strengthening the integrity of the 
health care system and ways in which the Affordable Care Act significantly bolsters that effort.   
 
Health Care Fraud, Waste, and Abuse:  Serious Issues That Must Be Addressed Trhough 
Concentrated and Sustained Efforts 
 
Fraud, waste, and abuse cost taxpayers billions of dollars each year and put beneficiaries health 
and welfare at risk.  The impact of these losses and risks is exacerbated by the growing number 
of people served by these programs and the increased strain on Federal and State budgets.  With 
new and expanded programs under the Affordable Care Act, it is critical that we strengthen 
oversight of these essential health care programs.   
 
Although there is no precise measure of health care fraud, we know that it is a serious problem 
that demands an aggressive response.  For example, over the past fiscal year, OIG has opened 
over 1,300 health care fraud investigations and obtained over 500 convictions.  OIG 
investigations also have resulted in nearly $3 billion in expected civil and criminal recoveries.  
While the majority of health care providers are honest and well-intentioned, a minority of 
providers who are intent on abusing the system can cost taxpayers billions of dollars. 
 
Health care fraud schemes commonly include billing for services that were not provided or were 
not medically necessary, purposely billing for a higher level of service than what was provided, 
misreporting costs or other data to increase payments, paying kickbacks, and/or stealing 
providers or beneficiaries identities.  The perpetrators of these schemes range from street 
criminals, who believe it is safer and more profitable to steal from Medicare than trafficking in 
illegal drugs, to Fortune 500 companies that pay kickbacks to physicians in return for referrals.   
 
Many OIG investigations target fraud committed by criminals who masquerade as Medicare 
providers and suppliers but who do not provide legitimate services or products.  The rampant 
fraud among durable medical equipment (DME) suppliers in south Florida is a prime example.  
In these cases, our investigations have found that criminals set up sham DME storefronts to 
appear to be legitimate providers, fraudulently bill Medicare for millions of dollars, and then 
close up shop and reopen in a new location under a new name and repeat the fraud.  The 
criminals often pay kickbacks to physicians, nurses, and even patients to recruit them as 
participants in the fraud schemes.     
 
____________________________________________________________________________________________________  1
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   The Medicare program is increasingly infiltrated by violent and organized criminal networks.  
For example, an individual in southern California led a Medicare DME fraud ring that 
established various fraudulent DME companies, primarily using street gang members to pose as 
nominee owners of his sham companies.  He paid each gang member $5,000 to establish bank 
accounts and to fill out the Medicare paperwork.  The nominee owners submitted claims for 
reimbursement to Medicare for power wheelchairs and orthotic devices that were not medically 
necessary or legitimately prescribed by a physician.  To date, nine of the gang members and 
associates have been indicted for charges including health care fraud and providing false 
statements to Government agencies.  The gang members involved in this fraud had previously 
been convicted of charges ranging from assault on a peace officer to numerous narcotics 
violations.   
 
Some fraud schemes are viral.  These schemes are replicated rapidly within geographic and 
ethnic communities.  Health care fraud also migrates  as law enforcement cracks down on a 
particular scheme, the criminals may relocate to a new geographic area or modify the scheme 
(e.g., suppliers have shifted from fraudulently billing for DME have shifted to fraudulent billing 
for home health services).  To combat this fraud, the Governments response must also be swift, 
agile, and coordinated. 
 
Health care fraud is not limited to blatant fraud by career criminals and sham providers.  Major 
corporations, such as pharmaceutical and medical device manufacturers, and institutions, such as 
hospitals and nursing facilities, have also committed fraud.  OIG has a strong record of 
investigating these corporate and institutional frauds, which often involve complex billing 
frauds, kickbacks, accounting schemes, illegal marketing, and physician self-referral 
arrangements.  In addition, we are seeing an increase in quality of care cases involving 
allegations of substandard care.   
 
Waste of funds and abuse of the health care programs also cost taxpayers billions of dollars.  In 
fiscal year (FY) 2009, the Centers for Medicare & Medicaid Services (CMS) estimated that 
overall, 7.8 percent of the Medicare fee-for-service claims it paid ($24.1 billion) did not meet 
program requirements.  Although these improper payments do not necessarily involve fraud, the 
claims should not have been paid.  For our part, OIG reviews claims for specific services, based 
on our assessments of risk, to identify improper payments.  For example, an OIG audit 
uncovered $275.3 million in improper Medicaid payments (Federal share) from 2004 to 2006 for 
personal care services in New York City.  As another example, an OIG evaluation of payments 
for facet joint injections (a pain management treatment) found that 63 percent of these services 
allowed by Medicare in 2006 did not meet program requirements, resulting in $96 million in 
improper payments.   
 
OIGs work has also demonstrated that Medicare and Medicaid pay too much for certain services 
and products and that aligning payments with market costs could produce substantial savings.  
For example, in 2007, OIG reported that Medicare reimbursed suppliers for pumps used to treat 
pressure ulcers and wounds based on a purchase price of more than $17,000, but that suppliers 
paid, on average, approximately $3,600 for new models of these pumps.  Similarly, we found 
that in 2007, Medicare allowed, on average, about $4,000 for standard power wheelchairs that 
cost suppliers, on average, about $1,000 to acquire.  These pricing disparities also affect 
____________________________________________________________________________________________________  2
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   beneficiaries, who are responsible for 20 percent copayments on items and services covered 
under Medicare Part B. 
 
OIGs Five-Principle Strategy Combats Health Care Fraud, Waste, and Abuse 
 
Combating health care fraud requires a comprehensive strategy of prevention, detection, and 
enforcement.  OIG has been engaged in the fight against health care fraud, waste, and abuse for 
more than 30 years.  Based on this experience and our extensive body of work, we have 
identified five principles of an effective health care integrity strategy.   
 
1.  Enrollment:  Scrutinize individuals and entities that want to participate as providers 
and suppliers prior to their enrollment or reenrollment in the health care programs. 
  
2.  Payment:  Establish payment methodologies that are reasonable and responsive to 
changes in the marketplace and medical practice. 
 
3.  Compliance:  Assist health care providers and suppliers in adopting practices that 
promote compliance with program requirements.   
 
4.  Oversight:  Vigilantly monitor the programs for evidence of fraud, waste, and abuse. 
 
5.  Response:  Respond swiftly to detected fraud, impose sufficient punishment to deter 
others, and promptly remedy program vulnerabilities. 
 
OIG uses these five principles in our strategic work planning to assist in focusing our audit, 
evaluation, investigative, enforcement, and compliance efforts most effectively.  These broad 
principles also underlie the specific recommendations that OIG makes to HHS and Congress.  
The Affordable Care Act includes provisions that reflect these principles and that we believe will 
support the fight against fraud, waste, and abuse in Medicare and Medicaid. 
 
The Affordable Care Act Enhances Health Care Oversight and Enforcement Activities 
 
The breadth and scope of health care reform alter the oversight landscape in many critical 
respects, and as a result OIG will assume a range of expanded oversight responsibilities.  The 
ACA provides us with expanded law enforcement authorities, opportunities for greater 
coordination among Federal agencies, and enhanced funding for the Health Care Fraud and 
Abuse Control (HCFAC) program.  In addition, new authorities for the Secretary and new 
requirements for health care providers, suppliers, and other entities will promote the integrity of 
the Medicare, Medicaid, and other Federal health care programs.  The following examples 
illustrate how the ACA will strengthen our oversight and enforcement efforts. 
 
Effective use of reliable data is critical to the Governments anti-fraud efforts.    
 
Section 6402 of the Affordable Care Act will enhance OIGs effectiveness in detecting fraud, 
waste, and abuse by expanding OIGs access to and uses of data for conducting oversight and 
law enforcement activities.  For example, section 6402 exempts OIG from the administrative 
____________________________________________________________________________________________________  3
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   requirements of matching data across programs in the Computer Matching and Privacy 
Protection Act and authorizes OIG to enter into data-sharing agreements with the Social Security 
Administration (SSA). 
 
The law also requires the Department to expand CMSs integrated data repository (IDR) to 
include claims and payment data from Medicaid, the Departments of Defense and Veterans 
Affairs, SSA, and the Indian Health Service and fosters data-matching agreements between 
Federal agencies.  These agreements will make it easier for the Federal Government to help 
identify fraud, waste, and abuse.     
 
Further, the ACA recognizes the importance of law enforcement access to data.  Access to real-
time claims data  that is, as soon as the claim is submitted to Medicare  is especially critical 
to identifying fraud as it is being committed.  Timely data is also essential to our ability to 
respond with agility as criminals shift their schemes and locations to avoid detection.  We have 
made important strides in obtaining data more quickly and efficiently, and the Affordable Care 
Act will further those efforts.   
 
In addition to claims data, access to records and other information is of critical importance to our 
mission.  Pursuant to section 6402 of the ACA, OIG may, for purposes of protecting Medicare 
and Medicaid integrity, obtain information from additional entities, such as providers, 
contractors, subcontractors, grant recipients, and suppliers, directly or indirectly involved in the 
provision of medical items or services payable by any Federal program.  This expanded authority 
will enable OIG to enhance Medicare and Medicaid oversight.  For example, OIG audits of Part 
D payments can now more effectively follow the documentation supporting claims all the way 
back to the prescribing physicians.   
   
Ensuring the integrity of information is also crucial, and the Affordable Care Act provides new 
accountability measures toward this end.  For example, section 6402 authorizes OIG to exclude 
from the Federal health care programs entities that provide false information on any application 
to enroll or participate in a Federal health care program.  The ACA also provides new civil 
monetary penalties for making false statements on enrollment applications; knowingly failing to 
repay an overpayment; and failing to grant timely access to OIG for investigations, audits, or 
evaluations. 
 
The Affordable Care Act provides the Secretary with new authorities and imposes new 
requirements that are consistent with OIGs recommendations.  
 
In addition to promoting data access and integrity, health care reform includes numerous 
program integrity provisions that support an effective health care integrity strategy.  Consistent 
with OIGs five-principle strategy, these include authorities and requirements to strengthen 
provider enrollment standards; promote compliance with program requirements; enhance 
program oversight, including requiring greater reporting and transparency; and strengthen the 
Governments response to health care fraud and abuse.  
 
Section 6401 of ACA requires the Secretary to establish procedures for screening providers and 
suppliers participating in Medicare, Medicaid, and the Childrens Health Insurance Program 
____________________________________________________________________________________________________  4
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   (CHIP).  The Secretary is to determine the level of screening according to the risk of fraud, 
waste, and abuse with respect to each category of provider or supplier.  At a minimum, providers 
and suppliers will be subject to licensure checks.  The ACA also authorizes the Secretary to 
impose additional screening measures based on risk, including fingerprinting, criminal 
background checks, multi-State database inquiries, and random or unannounced site visits.  
These statutory provisions address significant vulnerabilities that OIG has identified in 
Medicares enrollment standards and screening of providers and are consistent with 
recommendations that we have made to prevent unscrupulous providers and suppliers from 
participating in Medicare. 
 
Health care providers and suppliers must be our partners in ensuring the integrity of Federal 
health care programs and should adopt internal controls and other measures that promote 
compliance and prevent, detect, and respond to health care fraud, waste, and abuse.  OIG 
dedicates significant resources to promoting the adoption of compliance programs and providing 
guidance to health care providers on incorporating integrity safeguards into their organizations as 
an essential component of a comprehensive antifraud strategy.  For example, OIG is planning a 
Provider Compliance Training Initiative to bring together representatives from a variety of 
government agencies to provide compliance training at no cost to local provider, legal, and 
compliance communities.  The training sessions are scheduled to roll out in 2011 in several 
locations across the country.  We aim to educate communities about fraud risk areas uncovered 
by OIGs work and to share compliance best practices so that providers can strengthen their own 
compliance efforts and more effectively identify and avoid illegal schemes that may be targeting 
their communities.  This initiative will supplement OIGs extensive written guidance that is 
available on our Web site.  We believe these efforts to educate provider communities can help 
foster a culture of compliance and protect the Federal health care programs and beneficiaries.     
 
The Affordable Care Act require providers and suppliers to adopt, as a condition of enrollment, 
compliance programs that meet a core set of requirements, to be developed in consultation with 
OIG.  In addition, the ACA separately requires skilled nursing facilities and nursing facilities to 
implement compliance and ethics programs, also in consultation with OIG.  These new 
requirements are consistent with OIGs longstanding view that well-designed compliance 
programs can be an effective tool for promoting compliance and preventing fraud and abuse.  
These provisions are also consistent with recent developments in States that have made 
compliance programs mandatory for Medicaid providers.   
 
Consistent with OIG recommendations, the ACA also facilitates and strengthens program 
oversight by increasing transparency.  The new transparency requirements will shine light on 
financial relationships and potential conflicts of interest between health care companies and the 
physicians who prescribe their products and services.   
 
Specifically, section 6002 requires all U.S. manufacturers of drugs, devices, biologics, and 
medical supplies covered under Medicare, Medicaid, or CHIP to report information related to 
payments and other transfers of value to physicians and teaching hospitals.  This information will 
be made available on a public web site.  The types of payments subject to disclosure have been 
the source of conflicts of interest and, in some cases, part of illegal kickback schemes in many of 
OIGs enforcement cases.  OIG already includes similar disclosure requirements in our corporate 
____________________________________________________________________________________________________  5
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   integrity agreements with pharmaceutical manufacturers as part of the settlement of these cases.  
The requirement of public disclosure of these payments will help the Government, as well as the 
health care industry and the public, to monitor relationships and should have a sentinel effect to 
deter kickbacks and other inappropriate payment relationships. 
 
The quality of care in nursing homes also may improve with the increased transparency required 
by the Affordable Care Act.  Section 6101 requires nursing facilities and skilled nursing facilities 
to report ownership and control relationships.  Disclosure of these relationships is critical to 
facilitating better oversight of and response to quality-of-care and other issues.  Historically, law 
enforcement has struggled to determine responsibility within an organizations management 
structure.  We have had to resort to resource intensive and time-consuming investigative and 
auditing techniques to determine the roles and responsibilities of various management companies 
that are affiliated with a single nursing facility.  Establishing accountability is challenging in part 
because corporations sometimes intentionally construct byzantine structures that obscure 
responsible parties from view.  OIG has seen a variety of methods used to conceal true 
ownership, including establishing shell corporations, creating limited liability companies (LLC) 
to manage operations of individual homes, creating LLCs for real estate holdings, and creating 
affiliated corporations to lease and sublease among the various inter-owned corporations.  The 
new requirements for disclosure of ownership and control interests will help ensure that 
corporate owners and investment companies that own nursing homes will no longer be able to 
provide substandard care, deny responsibility, and leave underfunded shell companies to take the 
blame.  
 
Additional transparency provisions in the ACA will shine light on the administration of the 
Medicare and Medicaid programs.  Section 6402 will require Medicare and Medicaid program 
integrity contractors to provide performance statistics, including the number and amount of 
overpayments recovered, number of fraud referrals, and the return on investment (ROI) of such 
activities, to the Inspector General and the Secretary.  This latter requirement is consistent with 
OIGs call for greater accountability in the performance and oversight of CMSs program 
integrity contractors.   
 
In addition to strengthening the Governments ability to detect fraud and abuse, the Affordable 
Care Act strengthens the Governments ability to respond rapidly to health care fraud and hold 
perpetrators accountable.  For example, it expressly authorizes the Secretary, in consultation with 
OIG, to suspend payments to providers based on credible allegations of fraud.  Significantly, the 
ACA also increases criminal penalties under the Federal Sentencing Guidelines for Federal 
health care offenses and expands the types of conduct constituting Federal health care fraud 
offenses under Title 18 of the United States Code.  Put simply, criminals who commit health care 
fraud are going to be cut off from the Medicare Trust Funds faster, face longer prison terms, and 
be subject to larger criminal fines. 
 
Each of these integrity provisions advances the fight against fraud, waste, and abuse.  Further, 
we expect that the combined impacts of these new program integrity measures will be greater 
than the sum of the parts.  Preventing unscrupulous providers and suppliers from gaining access 
to the health care programs and beneficiaries is the first step in an integrated integrity strategy.  
Requiring compliance programs and providing guidance helps to ensure that those permitted to 
____________________________________________________________________________________________________  6
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   participate in the programs do not run afoul of the law or program requirements.  Expanded 
oversight and reporting requirements will help the Government, industry, and the public monitor 
the programs and identify potential fraud, waste, and abuse more quickly and effectively.  In 
combination, the ACAs new enforcement authorities and tools will help change the calculus 
undertaken by criminals when deciding whether to target Medicare and Medicaid by increasing 
the risk of prompt detection and the certainty of punishment.   
 
Funding of the Health Care Fraud and Abuse Control Program is vital to the fight against fraud, 
waste, and abuse. 
 
In addition to providing new authorities and enforcement tools, the Affordable Care Act provides 
critical new funding that will enable OIG to expand and strengthen current enforcement and 
oversight efforts to combat fraud, waste, and abuse.   
 
The HCFAC program is a comprehensive effort, under the joint direction of the Attorney 
General and the Secretary of HHS, acting through OIG, designed to coordinate Federal, state and 
local law enforcement activities with respect to health care fraud and abuse.  The HCFAC 
program provides OIGs primary funding stream to finance anti-fraud activities such as:   
 
  Support of Criminal and Civil False Claims Act investigations and enforcement;  
  Support of administrative enforcement activities; 
  Evaluations of Medicare contractor operations, Medicare and Medicaid reimbursement 
for prescription drugs and DME, and other issues;  
  Audits of payments to hospitals, home health agencies, Medicare Advantage plans, and 
Medicare Part D plans;  
  Expansion of our use of technology and innovative data analysis to enhance our oversight 
and enforcement activities; 
  Monitoring of providers under corporate integrity agreements; 
  Issuance of advisory opinions and other guidance to the health care industry; and  
  Establishment of Medicare Fraud Strike Force teams.1  
 
From its inception in 1997 through 2009, HCFAC Program activities have returned more than 
$15.6 billion to the Federal Government through audit and investigative recoveries, with a ROI 
of more than $4 for every $1 invested in OIG, DOJ, and FBI investigations, enforcement, and 
audits.2   HCFAC-funded activities have a further sentinel effect, which is not captured in this 
ROI calculation.  HCFAC-funded activities are a sound investment, and HHS and DOJ are 
receiving vital new HCFAC funding  $10 million per year for 10 years in FYs 20112020 under 
the ACA, and an additional $250 million total allocated across FYs 20112016 under the Health 
Care and Education Reconciliation Act of 2010.  With our share of this new funding, OIG will 
expand our Medicare and Medicaid investigations, audits, evaluations, enforcement, and 
compliance activities to support our efforts toward improving health care program integrity.   
                                                 
1 Medicare Fraud Strike Forces are a joint OIG-Department of Justice (DOJ) initiative used to fight concentrations 
of Medicare fraud in specific geographic hot spots.  Strike Force teams include special agents from OIG and the 
Federal Bureau of Investigation (FBI), DOJ prosecutors, and oftentimes State and local law enforcement officials. 
2 The $4 to $1 return on investment is a 3-year rolling average from 2006-2008, which is used to help account for 
the natural fluctuation in returns from investigative, enforcement, and audit activities. 
____________________________________________________________________________________________________  7
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   Innovative Uses of Data Are Central to OIGs Program Integrity Efforts  
 
Health care fraud schemes have become more sophisticated and better able to morph quickly in 
response to anti-fraud initiatives.  Innovative uses of information technology have dramatically 
enhanced OIGs ability to respond to this challenge.  For example, OIG is capitalizing on 
technology to process and review voluminous electronic evidence obtained during our health 
care fraud investigations.  Using Web-based investigative software, OIG can efficiently analyze 
large quantities of email or other electronic documents and identify associations among emails 
contained in multiple accounts based on content and metadata.  This technology is enabling 
investigators to complete in a matter of days analysis that used to take months with traditional 
investigative tools.  Recently, OIG expanded the impact of this cutting-edge technology by 
making it available to our law enforcement partners for use in joint investigations.  
 
Efficient and effective analysis of claims data to detect fraud indicators also is shaping how we 
deploy our law enforcement resources. OIG is using data to take a more proactive approach to 
identifying suspected fraud.  In 2009, OIG organized the multidisciplinary, multiagency 
Advanced Data Intelligence and Analytics Team (Data Team) to support the work of the Health 
Care Fraud Enforcement and Prevention Action Team (HEAT). The Data Team, composed of 
experienced OIG special agents, statisticians, programmers, and auditors and DOJ analysts, 
combines sophisticated data analysis with criminal intelligence gathered from special agents in 
the field to more quickly identify health care fraud schemes, trends, and geographic hot spots.  
For example, the Data Team has identified locations where billing for certain services is more 
than 10 times the national average. The Data Teams analyses inform the deployment of Strike 
Force resources and selection of new locations to focus and leverage Government resources in 
the areas with concentrations of health care fraud.  Medicare Fraud Strike Forces have been 
established in seven fraud hot spots  Miami, Los Angeles, Detroit, Houston, Brooklyn, Tampa, 
and Baton Rouge.  
 
We are committed to enhancing existing data analysis and mining capabilities and employing 
advanced techniques, such as predictive analytics and social network analysis, to counter new and 
existing fraud schemes.  As part of that commitment, we are developing a consolidated data access 
center, which will integrate business intelligence tools and data analytics into our fraud detection 
efforts.  It will also provide the opportunity to access, analyze, and share data  consistent with 
applicable privacy, security, and disclosure requirements  with our law enforcement partners.  This 
will enhance the efficiency and coordination of our collective efforts by giving law enforcement 
agents an opportunity to put the pieces together and see the totality of the fraud scheme.  
 
Through this data-enhanced collaboration, law enforcement will be able to increase the numbers of 
credible investigative leads, recoveries, and avoidances of improper Medicare and Medicaid 
payments and detect emerging fraud and abuse schemes and trends.  In addition, these tools will 
support our effective targeting of audits and evaluations to identify program vulnerabilities and 
recommend systemic solutions. 
 
Conclusion 
 
Health care fraud, waste, and abuse cost taxpayers billions of dollars every year and require 
focused attention and commitment to solutions.  The Affordable Care Act provides additional 
____________________________________________________________________________________________________  8
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010                                                                                                   authorities and resources that will significantly enhance our effectiveness in fighting health care 
waste, fraud, and abuse in the Medicare and Medicaid programs.  Through the dedicated efforts 
of OIG professionals and our collaboration with HHS and DOJ partners, we have achieved 
substantial results in the form of recoveries of stolen and misspent funds, enforcement actions 
taken against fraud perpetrators, improved methods of detecting fraud and abuse, and 
recommendations to remedy program vulnerabilities.  Thank you for your support of this 
mission.  I would be happy to answer any questions that you may have. 
____________________________________________________________________________________________________  9
House Committee on Energy and Commerce, Subcommittee on Health     
September 22, 2010